John M. Grange

Medicine · Health Sciences

50h-index9.1kcitations283works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Tuberculosis Research and Epidemiology(136), Mycobacterium research and diagnosis(108), Diagnosis and treatment of tuberculosis(28), Infectious Diseases and Tuberculosis(25), Immunotherapy and Immune Responses(20)

Publications282 total

Rapport du CGLPL du 3 octobre 2024 : des recours (encore) insuffisants face à l’indignité persistante des conditions carcérales
Revue des droits de l’homme·2025Open Access
Differential diagnosis of auditory nerve damage through amplitude modulation tests
2024Open Access
Immune protection against leukaemia
2017
Mycobacterial infections
Oxford University Press eBooks·2015
Mycobacterial infections
Oxford University Press eBooks·2015
Ancient Retrovirus Targeted by Engineered T Cells in Melanoma—Letter
Clinical Cancer Research·2015Open Access
The Concept of Hormesis in Cancer Therapy – Is Less More?
Cureus·2015· 24 citedOpen Access
Vaccination, Infection, and the Risk for Multiple Sclerosis
JAMA Neurology·2015· 3 cited
The biography of the immune system and the control of cancer: from St Peregrine to contemporary vaccination strategies
BMC Cancer·2014· 23 citedOpen Access
Mycobacterium tuberculosis – The Organism
2014· 5 cited
Is a hypothetical melanoma-like neuromelanin the underlying factor essential for the aetiopathogenesis and clinical manifestations of multiple sclerosis?
BMC Neurology·2013· 7 citedOpen Access
Childhood infectious diseases and risk of leukaemia in an adult population
International Journal of Cancer·2013· 2 citedOpen Access
Actinomyces, nocardia and tropheryma
Elsevier eBooks·2012· 1 cited
An intra-patient placebo-controlled phase I trial to evaluate the safety and tolerability of intradermal IMM-101 in melanoma
Annals of Oncology·2011· 53 citedOpen Access
Paradigms in multiple sclerosis: time for a change, time for a unifying concept
Inflammopharmacology·2011· 16 citedOpen Access
Tuberculosis and tubulointerstitial nephritis: an intriguing puzzle
Kidney International·2011· 21 citedOpen Access
Immune protection against tuberculosis – When is immunotherapy preferable to vaccination?
Tuberculosis·2011· 19 cited
Multiple Sclerosis: Are Protective Immune Mechanisms Compromised by a Complex Infectious Background?
Autoimmune Diseases·2010· 17 citedOpen Access
Viewpoint: Scientific dogmas, paradoxes and mysteries of latent <i>Mycobacterium tuberculosis</i> infection
Tropical Medicine & International Health·2010· 59 citedOpen Access
Is the eradication of tuberculosis ‘yesterday’s ambition’ or ‘tomorrow’s triumph’?
Clinical Medicine·2010· 7 citedOpen Access
page 1 of 15Next →

Frequent Co-authors

C.H. Collins(7), Alimuddin Zumla(7), M.D. Yates(6), C.J. Daborn(5), J.L. Stanford(5), Bernd Krone(5), Peter Mwaba(4), Giuseppe Mastrangelo(4), Ottorino Cosivi(3), Annette Pfahlberg(3), Olaf Gefeller(3), I. Botev(3), Marianne Niin(3), C Seebacher(3), D Lambert(3), Raphael Shafir(3), E. M. Kokoschka(3), Ulrich R. Kleeberg(3), G.A.W. Rook(3), Ross Davey(2)